We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,848 hedge funds and large institutions have $156B invested in Thermo Fisher Scientific in 2020 Q3 according to their latest regulatory filings, with 171 funds opening new positions, 628 increasing their positions, 775 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

205% more first-time investments, than exits

New positions opened: 171 | Existing positions closed: 56

22% more capital invested

Capital invested by funds: $128B → $156B (+$27.5B)

21% more funds holding in top 10

Funds holding in top 10: 163198 (+35)

6% more funds holding

Funds holding: 1,7491,848 (+99)

0.32% less ownership

Funds ownership: 89.48%89.16% (-0.32%)

18% less call options, than puts

Call options by funds: $613M | Put options by funds: $747M

19% less repeat investments, than reductions

Existing positions increased: 628 | Existing positions reduced: 775

Holders
1,848
Holders Change
+99
Holders Change %
+5.66%
% of All Funds
37.28%
Holding in Top 10
198
Holding in Top 10 Change
+35
Holding in Top 10 Change %
+21.47%
% of All Funds
3.99%
New
171
Increased
628
Reduced
775
Closed
56
Calls
$613M
Puts
$747M
Net Calls
-$134M
Net Calls Change
-$153M
Name Holding Trade Value Shares
Change
Change in
Stake
AWM
1001
Altavista Wealth Management
North Carolina
$1.72M -$35.9K -87 -2%
QCG
1002
Quadrant Capital Group
Ohio
$1.71M +$53.3K +129 +3%
CWM
1003
Confluence Wealth Management
Oregon
$1.71M +$209K +507 +9%
JCM
1004
Jacobsen Capital Management
Utah
$1.71M -$345K -834 -18%
SLF
1005
Sun Life Financial
Ontario, Canada
$1.7M -$211K -510 -12%
AIA
1006
Angeles Investment Advisors
California
$1.7M +$153K +370 +11%
CA
1007
Cetera Advisors
Colorado
$1.7M +$194K +469 +14%
CAM
1008
Cypress Asset Management
Texas
$1.7M +$45K +109 +3%
TF
1009
Tompkins Financial
New York
$1.69M -$35.5K -86 -2%
PG
1010
Prostatis Group
Maryland
$1.69M -$2.48K -6 -0.2%
PAM
1011
Paradigm Asset Management
New York
$1.69M -$248K -600 -14%
CIA
1012
Choate Investment Advisors
Massachusetts
$1.68M
ED
1013
Exane Derivatives
France
$1.66M -$12.8K -31 -0.8%
MCM
1014
Manchester Capital Management
Vermont
$1.66M -$429K -1,039 -22%
AG
1015
Algert Global
California
$1.66M +$1.55M +3,754 New
RC
1016
Roundview Capital
New Jersey
$1.65M +$24.4K +59 +2%
SAM
1017
Strategy Asset Managers
California
$1.65M +$15.7K +38 +1%
ZB
1018
Zions Bancorporation
Utah
$1.65M -$52.9K -128 -3%
PNAA
1019
Pictet North America Advisors
Switzerland
$1.65M +$93K +225 +6%
JWM
1020
JFG Wealth Management
Colorado
$1.64M +$1.54M +3,720 New
DWT
1021
Dorsey & Whitney Trust
South Dakota
$1.64M -$74.4K -180 -5%
MGWM
1022
Marks Group Wealth Management
Minnesota
$1.64M +$50.8K +123 +3%
CYG
1023
Clean Yield Group
Vermont
$1.63M -$7.02K -17 -0.5%
AT
1024
Arden Trust
Delaware
$1.63M +$90.9K +220 +6%
JFGIW
1025
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$1.62M +$1.04M +2,517 +218%

TMO Hedge Fund Activity: Q3 2020 in Review

1,848 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2020, worth a combined $156B — up 22% from $128B a quarter earlier.

Buyers outnumbered sellers: 171 funds opened new TMO positions and 56 closed out — a net gain of 115 holders — while 628 added to existing stakes and 775 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $295M. The largest seller was Massachusetts Financial Services, cutting an estimated $281M.

  • 1,848 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2020, up from 1,749 in Q2 2020.
  • Funds reported $156B of Thermo Fisher Scientific stock for Q3 2020, up 22% quarter-over-quarter.
  • 171 funds opened new Thermo Fisher Scientific positions in Q3 2020 and 56 closed out, a net change of +115 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2020 was Fidelity Investments, an estimated $295M added.
  • The largest Thermo Fisher Scientific seller in Q3 2020 was Massachusetts Financial Services, an estimated $281M sold.

Based on aggregated 13F filings for Q3 2020.